Lenovo Becomes Global Partner of Formula 1® in Renewed Deal
5.9.2024 17:00:00 CEST | Business Wire | Press release
Formula 1® and Lenovo have today announced the extension of its partnership that will see the technology giant elevated to a Global Partner in a multi-year renewal starting from the beginning of 2025. As part of the deal, Motorola, a subsidiary of Lenovo Group, will become Global Smartphone Partner of F1.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905029431/en/
(Photo: Business Wire)
As a Global Partner of Formula 1, Lenovo will continue to provide F1 with state-of-the-art technology devices, solutions and services to support the delivery of Grands Prix at track and remotely. Under the agreement, Lenovo will serve as the title sponsor for two races per season and Lenovo and Motorola will have increased trackside branding at events.
Since 2022, Lenovo technology has been at the heart of F1’s operations as an Official Partner. Through its on-site High-Performance Computing (HPC) solutions, servers and edge devices, Lenovo has been supporting Formula 1 in its delivery of its best-in-class broadcast product, bringing the drama and excitement of F1 to millions of fans around the world, with a truly global team that’s always-on. Lenovo hardware – including laptops, workstations, desktop computers and monitors, as well as tablets and Motorola smartphones – provide F1 staff with high-quality equipment to create engaging, customised content for the sport’s ever expanding and passionate fanbase.
Additionally, Lenovo’s Asset Recovery Service supports F1’s wider sustainability strategy, alongside its efforts to reduce emissions and reach Net Zero by 2030. Lenovo’s Asset Recovery Service helps ensure that retired computing hardware is recycled in a socially and environmentally conscious manner. Since the beginning of the partnership, F1 has sustainably disposed 95% of obsolete hardware, which ultimately helps to reduce costs and mitigate security risks through reliable data destruction with enhanced security.
Throughout the partnership, Lenovo has aimed to integrate smarter technology into the sport. The world’s first kiss-activated trophies at the FORMULA 1 LENOVO JAPANESE GRAND PRIX 2023 and FORMULA 1 LENOVO UNITED STATES GRAND PRIX 2023, along with this year’s laurel wreath design, combining tradition and innovation, elevated the podium celebrations and serve as strong symbols of Lenovo’s drive for purposeful design and cutting-edge technology.
In recent years, F1 has seen a significant growth in popularity, with increased television audiences, record attendance and fan engagement across all platforms. Both F1 and Lenovo share a commitment to sustainability and the exploration of next generation technologies, like Lenovo AI PCs, AI-enabled Motorola smartphones and AR/VR solutions.
Through direct collaboration between F1’s technical teams and Lenovo’s Centres of Excellence, highly innovative solutions are being found to a variety of challenges, such as the use of onsite and Edge Compute AI solutions to improve operational efficiency during live F1 broadcasts. Together, F1 and Lenovo will continue to build on years of successful collaboration to develop the future of the sport.
Stefano Domenicali, CEO and President of Formula 1 said:
“I am delighted that Lenovo will become a Global Partner of Formula 1. Since joining the sport Lenovo’s creativity and passion for technology and innovation have supported F1’s ambitions to create more once-in-a-lifetime moments for fans. Today marks a new chapter in a partnership that will only continue to grow from strength to strength. I look forward to continuing our work with Lenovo and using our shared commitment to precision, innovation, and sustainability to ensure F1 remains the world’s most technologically advanced sport for years to come.”
Yang Yuanqing, Chairman & CEO of Lenovo, said:
"We are thrilled to elevate our partnership to the next level becoming a Global Partner of Formula 1. Our vision at Lenovo is to harness the power of AI to create a smarter, more inclusive, and sustainable world, accessible to everyone. Through our groundbreaking partnerships, like the one with Formula 1, we are pushing the boundaries of innovation and performance. Together, we’re not just shaping the future of technology and motorsport, but we’re also ensuring that cutting-edge technological advancements benefit all, creating unforgettable experiences no matter where they are in the world."
Luca Rossi, President of Intelligent Devices Group, Lenovo, said:
“When we embarked on our journey with F1 three years ago, we knew they were the right partner for Lenovo as our brand values seamlessly aligned for a smarter, faster, and more sustainable future. Seeing our high-performance technology implemented across every level of the F1 organization fills us with pride, and our close collaboration together has just begun. We look forward to taking our partnership to newer heights and continue having Lenovo’s AI-ready hardware, as well as our solutions and services, transform and benefit the fan experience worldwide.”
About Formula 1®
Formula 1® racing began in 1950 and is the world’s most prestigious motor racing competition, as well as the world’s most popular annual sporting series. Formula One World Championship Limited is part of Formula 1® and holds the exclusive commercial rights to the FIA Formula One World Championship™. Formula 1® is a subsidiary of Liberty Media Corporation (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLVYK) attributed to the Formula One Group tracking stock. The F1 logo, F1 FORMULA 1 logo, FORMULA 1, F1, FIA FORMULA ONE WORLD CHAMPIONSHIP, GRAND PRIX, PADDOCK CLUB and related marks are trademarks of Formula One Licensing BV, a Formula 1 company. All rights reserved.
About Lenovo
Lenovo is a US$57 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905029431/en/
Contacts
Formula 1 Press Office
Formula 1 Press Office
E: f1media@f1.com
T: @f1media
Note: If you no longer wish to receive these emails, please write to f1media@f1.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom